Software Healthcare Sector

BGM Group

Market Cap: US$105.1m

Through its subsidiaries, operates as a pharmaceutical and chemical company in China.

Entasis Therapeutics Holdings

Market Cap: US$104.8m

Entasis Therapeutics Holdings Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of antibacterial products to treat serious infections caused by multidrug-resistant pathogens in the United States.

PolyPid

Market Cap: US$103.6m

A biopharmaceutical company, developing targeted, locally administered, and prolonged-release therapeutics using its proprietary polymer-lipid encapsulation matrix (PLEX) technology to address unmet medical needs.

Definitive Healthcare

Market Cap: US$103.4m

Provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally.

Polaryx Therapeutics

Market Cap: US$103.2m

A clinical-stage biotechnology company, engages in the discovery, development, and commercialization of disease-modifying therapies for rare and pediatric lysosomal storage disorders in the United States.

Yarrow Bioscience

Market Cap: US$102.0m

Operates as a clinical-stage biotechnology company that engages in developing transformative therapies for autoimmune thyroid diseases.

Island Pharmaceuticals

Market Cap: AU$140.6m

A drug repurposing company, focuses on the development of antiviral therapeutics for antiviral therapeutics in Australia and the United States of America.

Tenax Therapeutics

Market Cap: US$100.2m

A development-stage pharmaceutical company, develops novel cardiopulmonary therapies in the United States.

4basebio

Market Cap: UK£73.0m

Engages in the research, development, manufacturing, and sale of synthetic DNA and RNA products in Europe, the United States, and internationally.

Biomea Fusion

Market Cap: US$99.3m

A clinical-stage diabetes and obesity medicines company, focuses on the discovery and development of oral drugs to treat patients with diabetes and obesity.

Oneview Healthcare

Market Cap: AU$138.4m

Develops and sells software services for the healthcare sector in Ireland, the United States, Australia, the Middle East, and Asia.

Adicet Bio

Market Cap: US$98.9m

A clinical stage biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for autoimmune diseases and cancer in the United States.

Kalaris Therapeutics

Market Cap: US$98.8m

A clinical-stage biopharmaceutical company, engages in the development and commercialization of treatments for prevalent retinal diseases.

Microbot Medical

Market Cap: US$98.7m

A medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space.

NDT Pharmaceuticals

Market Cap: US$98.1m

A biotechnology company, focuses on developing various therapies for severe neurological disorders associated with traumatic brain Injury.

Park Dental Partners

Market Cap: US$98.0m

Operates as a dental resource organization that provides administrative business support services to dentists in Minnesota, Wisconsin, and Arizona.

Pelthos Therapeutics

Market Cap: US$97.7m

A bio-pharmaceutical company, develops and commercializes therapeutic products to help patients with unmet treatment burdens.

Atara Biotherapeutics

Market Cap: US$97.4m

Engages in the development of transformative therapies for patients with cancer and autoimmune disease in the United States and internationally.

Pulmonx

Market Cap: US$97.1m

A commercial-stage medical technology company that provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease.

Zhengye Biotechnology Holding

Market Cap: US$96.7m

Engages in the research, development, manufacture, and sale of veterinary vaccines for livestock in the People’s Republic of China.

Jushi Holdings

Market Cap: US$96.1m

Engages in the retail, distribution, cultivation, and processing of cannabis for medical and adult-use markets in the United States.

Fortress Biotech

Market Cap: US$95.7m

Operates as a biopharmaceutical company in the United States and internationally.

Hyperfine

Market Cap: US$95.7m

A health technology company, engages in the production, supply, service, and commercialization of magnetic resonance imaging (MRI) products.

BlinkLab

Market Cap: AU$133.3m

Focuses on the development and commercialization of intellectual property related to smartphone-based neurobehavioural testing.

electroCore

Market Cap: US$94.8m

A bioelectronic technology medicine and general wellness company, provides non-invasive vagus nerve stimulation (nVNS) technology platform in the United States, the United Kingdom, and internationally.

Acrivon Therapeutics

Market Cap: US$94.7m

A clinical-stage biopharmaceutical company, discovers and develops oncology medicines for patients whose tumors are predicted to be sensitive to each specific medicine by utilizing its generative phosphoproteomics platform.

Cognition Therapeutics

Market Cap: US$94.7m

A clinical-stage biopharmaceutical company, engages in the discovery and development of small molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina.

ECO Animal Health Group

Market Cap: UK£68.4m

ECO Animal Health Group plc, together with its subsidiaries, manufactured and supply animal health products internationally.

Accendra Health

Market Cap: US$92.3m

Operates as a healthcare solutions company in the United States.

HST Global

Market Cap: US$91.9m

Operates in the healthcare, software and media, and transportation industries.

Aldeyra Therapeutics

Market Cap: US$91.7m

A biotechnology company, discovers and develops therapies designed to treat immune-mediated diseases.

ImmuCell

Market Cap: US$91.4m

An animal health company, develops, manufactures, and sells products that improves the health and productivity of dairy and beef cattle in the United States and internationally.

Alcidion Group

Market Cap: AU$126.3m

Develops and sells digital health software solutions for healthcare organisations in Australia, New Zealand, and the United Kingdom.

Charlotte's Web Holdings

Market Cap: CA$124.8m

Engages in the farming, manufacturing, marketing, and sale of hemp-derived cannabidiol (CBD) and botanical-based wellness products in the United States.

Rallybio

Market Cap: US$89.4m

A clinical-stage biotechnology company, engages in the development and commercialization of life-transforming therapies for patients suffering from severe and rare diseases.

Poolbeg Pharma

Market Cap: UK£64.9m

A clinical-stage biopharmaceutical company, engages in developing immunotherapy for cancer in the United Kingdom.